Skip to content

    Coping with Ulcerative Colitis?

    Answer a few questions, and you'll get:

    • Tips for managing your symptoms everyday
    • Information on finding the support you need
    • Ways to discuss your illness with others

    Reviewed by Minesh Khatri, MD on August 07, 2017

    Sources:

    Gastroenterology: "AGA technical review on osteoporosis in gastrointestinal diseases," "American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease," "American Gastroenterological Association medical position statement: guidelines on osteoporosis in gastrointestinal diseases," "Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease."

    European Journal of Gastroenterology & Hepatology: "Bone loss associated with gastrointestinal disease: prevalence and pathogenesis."

    American Journal of Health-System Pharmacy: "New approaches to adherence issues when dosing oral aminosalicylates in ulcerative colitis."

    Journal of Clinical Psychology in Medical Settings: "Different associations of health related quality of life with pain, psychological distress, and coping strategies in patients with irritable bowel syndrome and inflammatory bowel disorder."

    Digestive and Liver Disease: "Instruments for quality of life assessment in patients with inflammatory bowel disease."

    Crohn's & Colitis Foundation of America: "Living with Ulcerative Colitis," "Bringing to Light the Risk of Colorectal Cancer among Crohn’s & Ulcerative Colitis Patients."

    National Institute for Health and Clinical Excellence (NICE): "Colonoscopic surveillance for prevention of colorectal cancer in people with ulcerative colitis, Crohn's disease or adenomas."

    Canadian Journal of Gastroenterology: "Exercise and inflammatory bowel disease."

    Clinical Epidemiology: "A clinical review of recent findings in the epidemiology of inflammatory bowel disease."

    UpToDate: "Management of mild to moderate ulcerative colitis in adults," "Approach to adults with steroid-refractory and steroid-dependent ulcerative colitis."

    Drug Design, Development and Therapy: "Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab."

    Mayo Clinic: "Vedolizumab better for UC than Crohn's disease in trials."

    Gut: "The safety of vedolizumab for ulcerative colitis and Crohn's disease."

    This tool does not provide medical advice. See additional information:

    THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE.  It is intended for informational purposes only. It is not a substitute for professional medical advice, diagnosis or treatment. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. If you think you may have a medical emergency, immediately call your doctor or dial 911.

    © 2017 WebMD, LLC. All rights reserved.